Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to their supply chains ...
Ondine Biomedical has reported a 40% relative reduction in 30-day surgical-site infections (SSIs) in a 5,188-patient phase 3 ...
Patients in Manchester could gain faster access to promising healthcare technologies through a new partnership between the Medicines and Healthcare products ...
Edinburgh-based biotechnology company Cytomos has appointed life sciences executive Dr Alex Jones as a non-executive director as it moves to … ...
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI in combination with MEKTOVI for the treatment of adult patients with advanced non-small cell lung cancer NSCLC) with a BRAFV600E ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results